Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00605228Phase 4Completed
Phase 4, randomised, single-blind trial of macrogol in bowel preparation (2 arms), sponsored by Norgine. Primary endpoint: Proportion of patients with successful colon cleansing as judged by blinded reviewers at 1 day. Started May 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00605228.